Evaluation of Clinical Parameters on Admission and Medications in Covid-19 Pneumonia (Corona Virus Disease 2019)

NCT04379310 · clinicaltrials.gov ↗

COMPLETED

Status

54

Enrollment

OTHER

Sponsor class

Conditions

Covid-19

Interventions

DRUG: ACE Inhibitors and Calcium Channel Blockers

Sponsor

Istanbul Nisantasi University